Market Share Drops to 82% in May... Challenges from Samsung Bioepis and Celltrion
Biosimilar Onslaught Dents Global Blockbuster Humira
The dominance of the autoimmune disease treatment Humira (active ingredient: adalimumab), once the world's best-selling drug, is waning. Sandoz's biosimilar Hyrimoz has rapidly gained market share,…